US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
US FDA expands use of allergic reaction nasal spray in people between 15-30 kilograms
The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
Healio6h
FDA approves epinephrine nasal spray for children aged as young as 4 years
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...
WebMD10h
FDA OKs Nasal Spray for Severe Allergic Reactions in Kids
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
San Diego biotech gets FDA approval for epi-pen alternative for kids
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
Managed Healthcare Executive7h
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 ...
PharmExec8h
FDA Approves ARS Pharmaceuticals’ neffy for Type 1 Allergic Reactions in Pediatric Patients
The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...
MedPage Today on MSN8h
New Congressman Dies; FDA Gets to Keep Lab; Americans Borrowed $74B for Healthcare
The Trump administration reversed a decision to terminate a lease for a major FDA drug testing lab in St. Louis. (Regulatory ...
GlobalData on MSN16h
FDA approves ARS’ neffy 1mg for paediatric anaphylaxis
The approval is supported by data from clinical trials, including pharmacodynamic and pharmacokinetic responses in adults and ...
BioSpace13h
ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...
The Pharma Letter12h
ARS Pharma wins new FDA approval for neffy
ARS Pharmaceuticals’ (Nasdaq: SPRY) shares closed up 3.4% at $10.87 yesterday, after the company announced that the US Food ...
MPR10h
Neffy 1mg Approved to Treat Severe Allergic Reactions in Younger Children
The Food and Drug Administration (FDA) has approved neffy ® (epinephrine nasal spray) 1mg for the emergency treatment of type 1 allergic reactions, including anaphylaxis, in pediatric patients aged 4 ...